Literature DB >> 22893404

Diabetes in Zucker diabetic fatty rat.

Masakazu Shiota1, Richard L Printz.   

Abstract

Male Zucker diabetic fatty fa/fa (ZDF) rats develop obesity and insulin resistance at a young age, and then with aging, progressively develop hyperglycemia. This hyperglycemia is associated with impaired pancreatic β-cell function, loss of pancreatic β-cell mass, and decreased responsiveness of liver and extrahepatic tissues to the actions of insulin and glucose. Of particular interest are the insights provided by studies of these animals into the mechanism behind the progressive impairment of carbohydrate metabolism. This feature among others, including the development of obesity- and hyperglycemia-related complications, is common between male ZDF rats and humans with type 2 diabetes associated with obesity. We discuss the diabetic features and complications found in ZDF rats and why these animals are widely used as a genetic model for obese type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893404     DOI: 10.1007/978-1-62703-068-7_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  29 in total

1.  Molecular changes in hepatic metabolism in ZDSD rats-A new polygenic rodent model of obesity, metabolic syndrome, and diabetes.

Authors:  Lu Han; Stefanie Bittner; Dachuan Dong; Yuan Cortez; Alex Bittner; Jackie Chan; Meenakshi Umar; Wen-Jun Shen; Richard G Peterson; Fredric B Kraemer; Salman Azhar
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-24       Impact factor: 5.187

2.  Ancient Wheat Diet Delays Diabetes Development in a Type 2 Diabetes Animal Model.

Authors:  Anne Cathrine Thorup; Søren Gregersen; Per Bendix Jeppesen
Journal:  Rev Diabet Stud       Date:  2015-02-10

3.  Polyphenol-rich bilberry ameliorates total cholesterol and LDL-cholesterol when implemented in the diet of Zucker diabetic fatty rats.

Authors:  Lea Brader; Ann Overgaard; Lars P Christensen; Per B Jeppesen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2014-02-10

4.  Portal milieu and the interplay of multiple antidiabetic effects after gastric bypass surgery.

Authors:  Atanu Pal; David B Rhoads; Ali Tavakkoli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-21       Impact factor: 4.052

5.  Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.

Authors:  J Jin; E R Machado; H Yu; X Zhang; Z Lu; Y Li; M F Lopes-Virella; K L Kirkwood; Y Huang
Journal:  J Dent Res       Date:  2013-12-18       Impact factor: 6.116

6.  Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity.

Authors:  Kiichiro Ueta; Tracy P O'Brien; Gregory A McCoy; Kuikwon Kim; Erin C Healey; Tiffany D Farmer; E Patrick Donahue; Audree B Condren; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-08       Impact factor: 4.310

7.  In Vivo Functional Assessment of Sodium-Glucose Cotransporters (SGLTs) Using [18F]Me4FDG PET in Rats.

Authors:  Yohji Matsusaka; Xinyu Chen; Paula Arias-Loza; Rudolf A Werner; Naoko Nose; Takanori Sasaki; Steven P Rowe; Martin G Pomper; Constantin Lapa; Takahiro Higuchi
Journal:  Mol Imaging       Date:  2022-06-21       Impact factor: 3.250

Review 8.  Noninvasive Neuromodulation of Peripheral Nerve Pathways Using Ultrasound and Its Current Therapeutic Implications.

Authors:  Christopher Puleo; Victoria Cotero
Journal:  Cold Spring Harb Perspect Med       Date:  2020-02-03       Impact factor: 6.915

9.  Effects of prolonged type 2 diabetes on mitochondrial function in cerebral blood vessels.

Authors:  Ivan Merdzo; Ibolya Rutkai; Venkata N L R Sure; Prasad V G Katakam; David W Busija
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-06       Impact factor: 4.733

10.  Limited Treatment Options for Diabetic Wounds: Barriers to Clinical Translation Despite Therapeutic Success in Murine Models.

Authors:  May Barakat; Luisa A DiPietro; Lin Chen
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-12-18       Impact factor: 4.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.